Bicycle Therapeutics Plc Share Price (NASDAQ: BCYC)
$7.1
Live
Last updated on
Check the interactive Bicycle Therapeutics Plc Stock chart to analyse performance
Bicycle Therapeutics Plc stock performance
as on August 26, 2025 at 12:42 AM IST
- Today's Low:$7.04Today's High:$7.21
0.85%
Downside
Day's Volatility :2.36%
Upside
1.53%
- 52 Weeks Low:$6.1052 Weeks High:$28.67
14.08%
Downside
52 Weeks Volatility :78.72%
Upside
75.24%
Bicycle Therapeutics Plc Stock Returns
Bicycle Therapeutics Plc Key Stats
Check Bicycle Therapeutics Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Bicycle Therapeutics Plc Stock including INR - Dollar returns
The Bicycle Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bicycle Therapeutics Plc investment value today
Current value as on today
₹35,827
Returns
Returns from Bicycle Therapeutics Plc Stock
Dollar Returns*
₹4,355 (+4.36%)
Indian investors sentiment towards Bicycle Therapeutics Plc Stock
Global Institutional Holdings in Bicycle Therapeutics Plc
Name
Holdings %
Baker Bros Advisors LP
15.72%
FCPM III SERVICES BV
4.99%
Armistice Capital, LLC
4.04%
Westfield Capital Management Company, L.P.
4.01%
Siren, L.L.C.
2.91%
Point72 Asset Management, L.P.
2.56%
Analyst Recommendation on Bicycle Therapeutics Plc Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 18 Wall street analysts offering stock ratings for Bicycle Therapeutics Plc(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Bicycle Therapeutics Plc Share Price Target
What analysts predicted
Upside of 236.75%
Target:
$23.91
Current:
$7.10
Bicycle Therapeutics Plc share price target is $23.91, a slight Upside of 236.75% compared to current price of $7.10 as per analysts' prediction.
Bicycle Therapeutics Plc Stock Insights
Price Movement
In the last 7 days, BCYC stock has moved down by -5.8%Decreasing Revenue
Revenue is down for the last 2 quarters, 9.97M → 2.92M (in $), with an average decrease of 70.7% per quarterDecreasing Net Profit
Netprofit is down for the last 6 quarters, -26.54M → -78.95M (in $), with an average decrease of 25.4% per quarterBCYC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 135.0%BCYC vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 185.4%Price to Sales
ForBCYC every $1 of sales, investors are willing to pay $25.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.
Bicycle Therapeutics Plc Financials
Bicycle Therapeutics Plc Technicals Summary
Sell
Neutral
Buy
Bicycle Therapeutics Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Bicycle Therapeutics Plc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -17.54% | -36.89% | -68.53% | -71.84% | -60.66% |
 | 5.52% | -17.35% | -50.85% | -1.12% | -3.68% |
 | 6.51% | 21.35% | 57.45% | 73.21% | 25.84% |
 | -14.26% | -17.97% | -18.13% | 40.27% | 45.64% |
 | 39.9% | 82.53% | 68.83% | 115.41% | 241.51% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -4.18 | -0.31 | -0.19 | NA | 9.66 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.08 | 28.08 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $492.1M | -60.66% | NA | 0.0% |
| Buy | $62.5B | -3.68% | 14.86 | 31.37% |
| NA | $38.3B | 25.84% | NA | -3.89% |
| Buy | $101.3B | 45.64% | 28.08 | 31.86% |
| Buy | $59.6B | 241.51% | NA | -12.96% |
About Bicycle Therapeutics Plc
Key Management of Bicycle Therapeutics Plc
Important FAQs about investing in BCYC Stock from India :
What is Bicycle Therapeutics Plc share price today?
Bicycle Therapeutics Plc share price today is $7.10 as on . Bicycle Therapeutics Plc share today touched a day high of $7.21 and a low of $7.04.
What is the 52 week high and 52 week low for Bicycle Therapeutics Plc share?
Bicycle Therapeutics Plc share touched a 52 week high of $28.67 and a 52 week low of $6.10. Bicycle Therapeutics Plc stock price today i.e. is trending at $7.10, lower by 75.24% versus the 52 week high.
How to invest in Bicycle Therapeutics Plc Stock (BCYC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bicycle Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicycle Therapeutics Plc Shares that will get you 0.2113 shares as per Bicycle Therapeutics Plc share price of $7.10 per share as on August 26, 2025 at 12:42 AM IST.
What is the minimum amount required to buy Bicycle Therapeutics Plc Stock (BCYC) from India?
Indian investors can start investing in Bicycle Therapeutics Plc (BCYC) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Bicycle Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on August 26, 2025).
Based on Bicycle Therapeutics Plc share’s latest price of $7.10 as on August 26, 2025 at 12:42 AM IST, you will get 1.4085 shares of Bicycle Therapeutics Plc. Learn more about
fractional shares .
What are the returns that Bicycle Therapeutics Plc has given to Indian investors in the last 5 years?
Bicycle Therapeutics Plc stock has given -60.66% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Global X S&p 500 Tail Risk Etf
$29.48
+0.1%
- Rareview Total Return Bond Etf
$25.12
-0.04%
S&p Pharmaceuticals Spdr Etf$46.62
-1.48%
- Cambria Value And Momentum Etf
$32.24
+0.28%
- Invesco Bs 2033 Hycb Etf
$25.36
+0.0%
Ishares Msci Peru And Global Exposure Etf$53.02
-0.39%
- Ishares Intl Div Growth Etf
$79.00
-1.1%
- Lg Qraft Ai-powered Us Large Cap Core Etf
$37.81
-0.45%
- Above Food Ingredients Inc Wt Exp 062829
$0.19
+0.0%